Literature DB >> 15723161

Alzheimer's disease: the impact of age-related changes in reproductive hormones.

C S Atwood1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15723161     DOI： 10.1007/s00018-004-4380-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  47 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Authors:  Louise R A Olde Nordkamp; Reinoud E Knops; Gust H Bardy; Yuri Blaauw; Lucas V A Boersma; Johannes S Bos; Peter Paul H M Delnoy; Pascal F H M van Dessel; Antoine H G Driessen; Joris R de Groot; Jean Paul R Herrman; Luc J L M Jordaens; Kirsten M Kooiman; Alexander H Maass; Mathias Meine; Yuka Mizusawa; Sander G Molhoek; Jurjen van Opstal; Jan G P Tijssen; Arthur A M Wilde
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

3.  Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators.

Authors:  J L Anderson; A P Hallstrom; A E Epstein; S L Pinski; Y Rosenberg; M O Nora; D Chilson; D S Cannom; R Moore
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

4.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

5.  Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Authors:  Stuart J Connolly; Paul Dorian; Robin S Roberts; Michael Gent; Steven Bailin; Eric S Fain; Kevin Thorpe; Jean Champagne; Mario Talajic; Benoit Coutu; Gerian C Gronefeld; Stefan H Hohnloser
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

6.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

7.  Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.

Authors:  S Adam Strickberger; John D Hummel; Thomas G Bartlett; Howard I Frumin; Claudio D Schuger; Scott L Beau; Cynthia Bitar; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

8.  Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.

Authors:  Hildegard Tanner; Gerhard Hindricks; Marius Volkmer; Steve Furniss; Volker Kühlkamp; Dominique Lacroix; Christian DE Chillou; Jesús Almendral; Domenico Caponi; Karl-Heinz Kuck; Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-28

9.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

10.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245
View more
  1 in total

Review 1.  Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics.

Authors:  Marie K Osterlund; Michael-Robin Witt; Jan-Ake Gustafsson
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.